Performance & Longevity Specialty Testing

Early Detection of Alzheimer's Disease with the p-Tau217 Biomarker is Intended for adult patients aged 45 and older who present with cognitive impairment and are being evaluated for AD or other causes of  cognitive decline.

Clinical Indications for Testing: 

• Cardiovascular disease
• Fatigue
• Malnutrition
• Maldigestion/Malabsorption
• Athletic performance [21,22]
• Physical trauma/healing [16,23,24]
• Obesity/ Insulin resistance/ Type 2 Diabetes [10,11,12,13]
• Weight Issues/ Dietary Guidance [13,18]
• Mood disorders [2,3,4,5,6,7]

The Methylation Panel can uncover needs for nutritional support such as amino acids, vitamins, and minerals. Knowing this can help guide dietary and nutraceutical treatment plans. Additionally, knowing genetic predispositions can help focus supplementation to override potential methylation defects. 

At home cheek swab, no blood draw required!